> 博客

Navigating BPOM Registration for New Supplement Ingredients in Indonesia

Navigating BPOM Registration for New Supplement Ingredients in Indonesia

Fachrurrodji 博士,运动机能学专家
3 月 22, 2026

内容

Entering the Indonesian health and wellness market offers a massive opportunity for international brands. However, the gatekeeper to this market is the Indonesian Food and Drug Authority, known as 业务流程对象模型 (Badan Pengawas Obat dan Makanan). Achieving a successful BPOM注册 is the most critical milestone for any manufacturer or distributor. While many vitamins and minerals follow a standard path, things get complicated when your formula contains “novel” or “unlisted” ingredients. If your active material is not found on the standard regulatory lists, you must navigate a specific set of procedures to ensure your product can legally reach Indonesian consumers.

In this comprehensive guide, we will break down how to handle supplement ingredients that fall outside the current “Positive List,” ensuring your path to market entry is as smooth and predictable as possible.

Understanding the Regulatory Landscape of BPOM Registration

Before diving into the technicalities of screening ingredients, it is vital to understand how 业务流程对象模型 categorizes substances. The Indonesian regulator maintains a strict framework to protect public health, which means every single component of your supplement is scrutinized.

The Two Primary Lists

Generally, BPOM refers to two main documents during the initial evaluation of a health supplement:

  1. The Positive List (Allowed Ingredients): This is an exhaustive catalog of vitamins, minerals, amino acids, and botanicals that are already pre-approved. These items usually come with predefined maximum daily intake limits. If your product stays within these limits, the BPOM注册 process is relatively straightforward.
  2. The Negative List (Prohibited Ingredients): This list includes substances that are strictly banned from health supplements. This includes potent medicinal chemicals (BKO), certain dangerous plants, or substances with high toxicity profiles.

The “Grey Area” of Novel Ingredients

The challenge for many healthcare companies expanding to Southeast Asia is the “Grey Area.” This occurs when an ingredient is neither on the Positive List nor the Negative List. In the world of innovative nutraceuticals, many cutting-edge supplement ingredients fall into this category. If you find yourself in this position, you do not necessarily need to panic, but you do need a strategic plan for BPOM注册.

Step 1: Proactive Screening and Verification for BPOM Registration

The first rule of Indonesian market entry is: never assume. Just because an ingredient is widely sold in the United States or Europe does not mean it is automatically recognized by Indonesian authorities. The most efficient way to start is through a meticulous process of screening ingredients against BPOM’s internal (non-public) database.

Bypassing the Long Path

It is a common misconception among foreign manufacturers that every unlisted ingredient requires a full, multi-month safety assessment. In reality, BPOM’s internal database is often more updated than the publicly available PDF lists. An ingredient might already be approved for another company but hasn’t been added to the public gazette yet.

How to Verify Your Ingredient Status

To save time and resources, use these official channels before filing a formal application:

  • The ASROT Database: Check the Aplikasi Sertifikasi & Registrasi Obat Tradisional (ASROT) electronic system. During the draft stage, check if the material appears in the drop-down selection menus.
  • The BPOM Helpdesk: Reach out via official WhatsApp or phone channels dedicated to health supplements. Often, a quick query can reveal if the ingredient is already “known” to the system.
  • Formal Consultation: For complex formulas, booking a consultation session with BPOM evaluators is the gold standard. This allows you to present your formula and get immediate feedback on whether it is acceptable or requires further data.

The Importance of the Written Record

One of the most critical tips for BPOM注册 success involves documentation. If you receive a verbal “OK” during a consultation, it is not legally binding. You must draft a “Minutes of Meeting” (MoM) and send it to the evaluator via email immediately after the session. This creates a paper trail that serves as evidence during the formal audit stage.

Step 2: The Assessment Path for New Supplement Ingredients

If your verification efforts confirm that the ingredient is truly “new” to the Indonesian regulator, you must undergo a formal Assessment (locally known as Pengkajian). This is a separate process that must be completed before the actual BPOM注册 of the finished product can begin.

Necessary Documentation for Safety and Efficacy

To pass this stage, you must provide a comprehensive scientific dossier. BPOM requires more than just a Marketing Brochure; they need hard scientific data. When screening ingredients for this path, ensure you have the following:

  • General Identity: This includes the INN name, the Indonesian name, the CAS number, and the chemical structure.
  • Critical Safety Data: You must provide toxicity studies, including Acute (LD50), sub-chronic, or chronic toxicity reports.
  • Global Recognition: BPOM looks for international safety status. If the ingredient is recognized as GRAS (Generally Recognized as Safe) by the US FDA or has a WHO monograph, your chances of approval increase significantly.
  • The “Three Country” Rule: One of the unique requirements in Indonesia is proving that the ingredient is already regulated and sold as a supplement in at least three other countries. This demonstrates global acceptance and a history of safe use.

Preparing Your Supplier

Many manufacturers fail at this stage because their raw material suppliers are unwilling or unable to provide the necessary data. A standard MSDS (Material Safety Data Sheet) is insufficient for BPOM注册 of a new ingredient. You must demand specific NOAEL (No Observed Adverse Effect Level) data and published scientific journals from your suppliers.

Timelines and Expectations for BPOM Registration

Time-to-market is a critical factor for any business. When dealing with new supplement ingredients, you must factor the assessment timeline into your business plan.

The 85-Day Evaluation

Once your application for assessment is declared complete and the fees are paid, BPOM typically evaluates the data within 85 working days. Note that “working days” in Indonesia exclude weekends and public holidays. If the evaluators request additional data (a “Request for Information” or RFI), the clock stops until you provide the answers.

Possible Outcomes

  1. Approval: You will receive a formal decision letter (SK) stating the ingredient is approved for use. At this point, you can proceed to the standard BPOM注册 via the ASROT system.
  2. Rejection: If the safety data is deemed insufficient, the ingredient cannot be used. You will have to reformulate your product for the Indonesian market.

Strategic Advice for International Manufacturers

Successfully navigating BPOM注册 requires a blend of scientific expertise and local regulatory “know-how.” For foreign medical device manufacturers or healthcare companies expanding to Southeast Asia, we recommend the following strategies:

Do Not Rely on Global Equivalence

Every country has its own sovereignty regarding food and drug safety. A common pitfall is assuming that a European CE mark or a US FDA approval guarantees an automatic pass in Indonesia. While these credentials help, they are supplementary to the specific Indonesian requirements.

Plan for the Delay

A full ingredient assessment typically adds approximately 4 to 5 months to your product launch timeline. If your business strategy requires a rapid launch, it is often wiser to stick to ingredients already on the Positive List for your “Version 1.0” product, while simultaneously filing for the assessment of your more “innovative” ingredients for a future “Version 2.0” launch.

Professional Ingredient Screening

Before shipping samples or signing distribution agreements, perform a deep dive into screening ingredients. Identifying a “red flag” ingredient early can save tens of thousands of dollars in wasted registration fees and lost time.

Conclusion: Securing Your BPOM Registration Success

Navigating the complexities of the Indonesian regulatory environment can be daunting, but it is a manageable process with the right preparation. Whether your formula contains standard vitamins or cutting-edge supplement ingredients, the key to success lies in proactive communication and robust scientific documentation.

By following the two-step strategy of Verification and Assessment, you ensure that your BPOM注册 is built on a solid foundation. Remember to always document your consultations, demand high-quality toxicity data from your suppliers, and respect the local timelines set by the Indonesian authorities. With a structured approach, your products will not only meet compliance standards but also gain the trust of the Indonesian consumers who rely on BPOM’s rigorous oversight.

Frequently Asked Questions (FAQs)

1. How long does the total BPOM registration process take for a new supplement?

If the ingredients are already on the Positive List, the process typically takes 6 to 12 months. However, if a new ingredient assessment is required, you should add another 4 to 5 months to that timeline.

2. Can I register a supplement if I am a foreign company without a local office?

No. To hold a BPOM注册 number (NIE), you must have a local legal entity in Indonesia, such as a PTPM (Local Company) or a BUJKA, or you must appoint a local distributor to act as your Registration Holder.

3. What is the “Three Country” rule for new supplement ingredients?

BPOM requires evidence that a new or novel ingredient has been legally marketed as a health supplement in at least three other countries. This is used as a benchmark for international safety and acceptance.

4. Is an MSDS enough to prove the safety of an ingredient?

No. A Material Safety Data Sheet (MSDS) is generally considered insufficient for a new ingredient assessment. BPOM specifically requires toxicity studies (such as LD50 and sub-chronic toxicity) and NOAEL data to determine safe dosage limits.

5. What happens if BPOM rejects one ingredient in my multi-ingredient formula?

If one ingredient is rejected, the entire formula cannot be registered as-is. You will need to remove or replace that specific ingredient and restart the BPOM注册 process for the updated formula.

Dr. Fachrurrodji, Sp.PK的图片
Fachrurrodji 博士,运动机能学专家
法赫鲁罗吉博士是一位专攻临床病理学的专家,同时也是医疗器械和体外诊断领域的资深顾问,致力于弥合实验室医学与监管合规之间的鸿沟。他的专长涵盖诊断的整个生命周期,从临床验证和质量保证到血液学和传染病领域复杂数据的解读。凭借丰富的病理学实践经验和严谨的监管知识,他为三类临床试验提供咨询,确保新的诊断技术在广泛应用前符合严格的安全性和性能标准。.
获取最新的产品注册更新
订阅电子报

咨询表

我们的团队随时准备与您探讨您的业务需求,并解答您的任何疑问。请填写我们的咨询表格,我们将在一个工作日内回复。.

Contact Form (CN)
Submit with your company email for quicker response and priority handling.

其他联系我们的方式。.

相关文章
Navigating the 2026 BPOM Regulation: A Guide to Processed Food Recall and Destruction
无声的威胁:印尼天然药物中重金属含量的限制
确保安全:了解天然药物中的致病性肠杆菌科细菌
Navigating the 2026 BPOM Regulation: A Guide to Processed Food Recall and Destruction
无声的威胁:印尼天然药物中重金属含量的限制
Navigating the 2026 BPOM Regulation: A Guide to Processed Food Recall and Destruction